awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38672008-D9C7E446-12E0-4B7A-AD9E-85EE17595B20
Q38672008-D9C7E446-12E0-4B7A-AD9E-85EE17595B20
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38672008-D9C7E446-12E0-4B7A-AD9E-85EE17595B20
An economic analysis of high-dose imatinib, dasatinib, and nilotinib for imatinib-resistant chronic phase chronic myeloid leukemia in China: A CHEERS-compliant article.
P2860
Q38672008-D9C7E446-12E0-4B7A-AD9E-85EE17595B20
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38672008-D9C7E446-12E0-4B7A-AD9E-85EE17595B20
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
82d597a544355db6330bdabffdd3c1b27977372c
P2860
Cost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia.